In cases of benign disease, vaginal hysterectomy is preferred approach

Article

The vaginal route is preferable to the open abdominal route and to the laparoscopic technique for hysterectomy for benign disease, according to an American College of Obstetrics and Gynecology (ACOG) committee opinion.

The vaginal route is preferable to the open abdominal route and to the laparoscopic technique for hysterectomy for benign disease, according to a recent American College of Obstetrics and Gynecology (ACOG) committee opinion.

Of the 600,000 hysterectomies performed in the United States each year, 40.7% are performed to treat fibroids, 17.7% to treat endometriosis, and 14.5% to treat uterine prolapse.

A review of available evidence led the committee to conclude that, for the majority of women, the vaginal approach provides better outcomes, faster recovery, fewer complications, and greater cost-efficacy than the other 2 options.

Currently in the United States, about 66% of hysterectomies for benign disease are performed abdominally, about 22% are performed vaginally, and about 12% are performed laparoscopically.

ACOG Committee Opinion No. 444: Choosing the route of hysterectomy for benign disease. Obstet Gynecol. 2009;114(5):1156-1158.

Recent Videos
Supreme Court upholds mifepristone access: Implications for women's health | Image Credit: linkedin.com
The significance of the Supreme Court upholding mifepristone access | Image Credit: unchealth.org
One year out: Fezolinetant displays patient satisfaction for managing hot flashes | Image Credit: sutterhealth.org
Addressing maternal health inequities: Insights from CDC's Wanda Barfield | Image Credit: cdc.gov
Addressing racial and ethnic disparities in brachial plexus birth Injury | Image Credit: shrinerschildrens.org
Innovations in prenatal care: Insights from ACOG 2024 | Image Credit:  uofmhealth.org.
Unlocking therapeutic strategies for menopausal cognitive decline | Image Credit: uclahealth.org.
Navigating menopause care: Expert insights from ACOG 2024 | Image Credit: mayo.edu.
© 2024 MJH Life Sciences

All rights reserved.